NX Prenatal

NX Prenatal is developing a maternal blood test which is positioned to become the industry’s first EARLY warning system for preterm birth (as early as week 10 of pregnancy). The test is designed to help identify which asymptomatic pregnancies may result in the ~60% of 500,000 annual preterm births in the US that occur without warning.

nxprenatal.com

Back to Companies

Gail Page
Chairman & Co-CEO